IFP Advisors’s Agios Pharmaceuticals AGIO Stock Holding History
Bought
Maintained
Sold
Other funds holding AGIO
IFP Advisors's AGIO Position: Q3 2026 in Review
IFP Advisors held its Agios Pharmaceuticals (AGIO) position steady in Q3 2026 at 233 shares worth $7.75K. The position accounts for ﹤0.01% of the portfolio, ranked #3561.
IFP Advisors first reported a position in AGIO in Q4 2015 and has held it in 16 quarters since. The position peaked at $15K in Q4 2015. 243 funds tracked by Wall St. Rank hold AGIO as of Q3 2026.
- IFP Advisors held 233 shares of Agios Pharmaceuticals worth $7.75K as of Q3 2026.
- IFP Advisors left its Agios Pharmaceuticals share count unchanged in Q3 2026.
- Agios Pharmaceuticals made up ﹤0.01% of IFP Advisors's portfolio in Q3 2026, its #3561 holding.
- IFP Advisors first reported a position in Agios Pharmaceuticals in Q4 2015 and has held it in 16 quarters since.
- IFP Advisors's Agios Pharmaceuticals position peaked at $15K in Q4 2015.
- 243 funds tracked by Wall St. Rank held Agios Pharmaceuticals as of Q3 2026.
Based on IFP Advisors's 13F filing for Q3 2026, filed 16 Oct 2026.